-
Intensive care medicine · Apr 2005
Randomized Controlled Trial Comparative Study Clinical TrialAntibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.
- A Acquarolo, T Urli, G Perone, C Giannotti, A Candiani, and N Latronico.
- Institute of Anesthesiology-Intensive Care, University of Brescia Spedali Civili, Piazzale Ospedali Civili 1, 25125 Brescia, Italy. a.acquarolo@tiscali.it
- Intensive Care Med. 2005 Apr 1;31(4):510-6.
ObjectiveTo evaluate if a 3-day ampicillin-sulbactam prophylaxis can reduce the occurrence of early-onset pneumonia (EOP) in comatose mechanically-ventilated patients.DesignThis was a single-centre, prospective, randomised, open study.SettingA 10-bed general-neurological ICU in a 2,000-bed university hospital.Patients And ParticipantsComatose mechanically-ventilated patients with traumatic, surgical or medical brain injury.InterventionsPatients were randomized to either ampicillin-sulbactam prophylaxis (3 g every 6 h for 3 days) plus standard treatment or standard treatment alone.Measurements And ResultsMain outcome was the occurrence of EOP. Secondary outcome measures were occurrence of late-onset pneumonia, percentage of non-pulmonary infections and of emerging multiresistant bacteria, duration of mechanical ventilation and of ICU stay and ICU mortality. Interim analysis at 1 year demonstrated a statistically significant reduction of EOP in the ampicillin-sulbactam group, and the study was interrupted. Overall, 39.5% of the patients developed EOP, 57.9% in the standard treatment group and 21.0% in the ampicillin-sulbactam group (chi-square 5.3971; P =0.022). Relative risk reduction of EOP in patients receiving ampicillin-sulbactam prophylaxis was 64%; the number of patients to be treated to avoid one episode of EOP was three. No differences in other outcome parameters were found; however, the small sample size precluded a definite analysis.ConclusionsAntibiotic prophylaxis with ampicillin-sulbactam significantly reduced the occurrence of EOP in critically ill comatose mechanically ventilated patients. This result should encourage a large multicenter trial to demonstrate whether ampicillin-sulbactam prophylaxis reduces patient mortality, and whether antibiotic resistance is increased in patients receiving prophylaxis.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:

- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.